Literature DB >> 8168127

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic.

J B Gibbs1, A Oliff, N E Kohl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8168127     DOI： 10.1016/0092-8674(94)90308-5

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  82 in total

1.  Molecular Events as Targets of Anticancer Drug Therapy.

Authors:  Adorján Aszalós; Sándor Eckhardt
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

Review 2.  Evolving therapies: farnesyltransferase inhibitors.

Authors:  W Thomas Purcell; Ross C Donehower
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

3.  In vitro and in vivo growth inhibition of human malignant astrocytoma cells by the farnesyltransferase inhibitor B1620.

Authors:  Masanori Kurimoto; Yutaka Hirashima; Hideo Hamada; Hironaga Kamiyama; Shoichi Nagai; Nakamasa Hayashi; Shunro Endo
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

4.  K-Ras-independent effects of the farnesyl transferase inhibitor L-744,832 on cyclin B1/Cdc2 kinase activity, G2/M cell cycle progression and apoptosis in human pancreatic ductal adenocarcinoma cells.

Authors:  S Y Song; I M Meszoely; R J Coffey; J A Pietenpol; S D Leach
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 5.  Current approaches and future strategies for pancreatic carcinoma.

Authors:  R A Wolff; P Chiao; R Lenzi; P W Pisters; J E Lee; N A Janjan; C H Crane; D B Evans; J L Abbruzzese
Journal:  Invest New Drugs       Date:  2000-02       Impact factor: 3.850

Review 6.  Protein farnesylation and disease.

Authors:  Giuseppe Novelli; Maria Rosaria D'Apice
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

Review 7.  How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.

Authors:  Ethan J Brock; Kyungmin Ji; John J Reiners; Raymond R Mattingly
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

8.  Mutant farnesyltransferase beta subunit of Saccharomyces cerevisiae that can substitute for geranylgeranyltransferase type I beta subunit.

Authors:  H Mitsuzawa; K Esson; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Actinoplanic acids A and B as novel inhibitors of farnesyl-protein transferase.

Authors:  K C Silverman; C Cascales; O Genilloud; J M Sigmund; S E Gartner; G E Koch; M M Gagliardi; B K Heimbuch; M Nallin-Omstead; M Sanchez
Journal:  Appl Microbiol Biotechnol       Date:  1995 Aug-Sep       Impact factor: 4.813

10.  NMR studies of novel inhibitors bound to farnesyl-protein transferase.

Authors:  K S Koblan; J C Culberson; S J Desolms; E A Giuliani; S D Mosser; C A Omer; S M Pitzenberger; M J Bogusky
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.